vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与SWK Holdings Corp（SWKH）财务数据对比。点击上方公司名可切换其他公司
CUMBERLAND PHARMACEUTICALS INC的季度营收约是SWK Holdings Corp的1.6倍（$13.7M vs $8.7M），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs -29.7%），SWK Holdings Corp自由现金流更多（$26.8M vs $3.0K），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs -12.5%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
SWK Holdings Corp是一家专注于医疗健康与生命科学领域的专业金融企业，为生物技术、制药、医疗器械及诊断类企业提供特许权使用费货币化、结构性债务、资产支持贷款等定制化融资服务，核心市场以北美地区为主。
CPIX vs SWKH — 直观对比
营收规模更大
CPIX
是对方的1.6倍
$8.7M
营收增速更快
CPIX
高出60.8%
-29.7%
自由现金流更多
SWKH
多$26.8M
$3.0K
两年增速更快
CPIX
近两年复合增速
-12.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $8.7M |
| 净利润 | $-1.4M | $-19.4M |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | 9.9% |
| 净利率 | -10.3% | — |
| 营收同比 | 31.1% | -29.7% |
| 净利润同比 | 25.8% | -430.2% |
| 每股收益（稀释后） | $-0.09 | $-1.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXSWKH
| Q4 25 | $13.7M | $8.7M | ||
| Q3 25 | $8.3M | $10.9M | ||
| Q2 25 | $10.8M | $10.1M | ||
| Q1 25 | $11.7M | $11.8M | ||
| Q4 24 | $10.4M | $12.4M | ||
| Q3 24 | $9.1M | $10.4M | ||
| Q2 24 | $9.8M | $10.8M | ||
| Q1 24 | $8.5M | $11.4M |
净利润CPIXSWKH
| Q4 25 | $-1.4M | $-19.4M | ||
| Q3 25 | $-1.9M | $8.8M | ||
| Q2 25 | $-740.7K | $3.5M | ||
| Q1 25 | $1.3M | $4.5M | ||
| Q4 24 | $-1.9M | $5.9M | ||
| Q3 24 | $-1.5M | $3.5M | ||
| Q2 24 | $-1.1M | $3.7M | ||
| Q1 24 | $-1.9M | $468.0K |
毛利率CPIXSWKH
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXSWKH
| Q4 25 | -10.0% | 9.9% | ||
| Q3 25 | -23.7% | 61.3% | ||
| Q2 25 | -6.9% | 46.1% | ||
| Q1 25 | 11.0% | 68.6% | ||
| Q4 24 | -17.7% | 44.7% | ||
| Q3 24 | -18.6% | 39.2% | ||
| Q2 24 | -10.4% | 8.3% | ||
| Q1 24 | -22.0% | 9.5% |
净利率CPIXSWKH
| Q4 25 | -10.3% | — | ||
| Q3 25 | -23.4% | 80.7% | ||
| Q2 25 | -6.8% | 35.2% | ||
| Q1 25 | 10.7% | 38.4% | ||
| Q4 24 | -18.2% | 47.5% | ||
| Q3 24 | -17.0% | 33.3% | ||
| Q2 24 | -11.0% | 33.9% | ||
| Q1 24 | -22.9% | 4.1% |
每股收益（稀释后）CPIXSWKH
| Q4 25 | $-0.09 | $-1.59 | ||
| Q3 25 | $-0.13 | $0.72 | ||
| Q2 25 | $-0.05 | $0.29 | ||
| Q1 25 | $0.08 | $0.37 | ||
| Q4 24 | $-0.13 | $0.47 | ||
| Q3 24 | $-0.11 | $0.28 | ||
| Q2 24 | $-0.08 | $0.30 | ||
| Q1 24 | $-0.14 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $42.8M |
| 总债务越低越好 | — | $33.0M |
| 股东权益账面价值 | $24.9M | $235.1M |
| 总资产 | $76.8M | $272.4M |
| 负债/权益比越低杠杆越低 | — | 0.14× |
8季度趋势，按日历期对齐
现金及短期投资CPIXSWKH
| Q4 25 | $11.4M | $42.8M | ||
| Q3 25 | $15.2M | $10.2M | ||
| Q2 25 | $16.1M | $8.0M | ||
| Q1 25 | $15.1M | $29.8M | ||
| Q4 24 | $18.0M | $5.9M | ||
| Q3 24 | $17.5M | $17.2M | ||
| Q2 24 | $17.3M | $5.5M | ||
| Q1 24 | $18.5M | $5.5M |
总债务CPIXSWKH
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
股东权益CPIXSWKH
| Q4 25 | $24.9M | $235.1M | ||
| Q3 25 | $26.1M | $254.2M | ||
| Q2 25 | $28.0M | $246.5M | ||
| Q1 25 | $28.7M | $292.7M | ||
| Q4 24 | $22.9M | $288.7M | ||
| Q3 24 | $24.8M | $283.4M | ||
| Q2 24 | $26.3M | $282.8M | ||
| Q1 24 | $27.5M | $279.9M |
总资产CPIXSWKH
| Q4 25 | $76.8M | $272.4M | ||
| Q3 25 | $65.9M | $289.4M | ||
| Q2 25 | $67.9M | $285.7M | ||
| Q1 25 | $69.9M | $331.3M | ||
| Q4 24 | $75.6M | $332.2M | ||
| Q3 24 | $76.7M | $321.3M | ||
| Q2 24 | $78.5M | $321.0M | ||
| Q1 24 | $81.5M | $322.0M |
负债/权益比CPIXSWKH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $27.3M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $26.8M |
| 自由现金流率自由现金流/营收 | 0.0% | 308.1% |
| 资本支出强度资本支出/营收 | 0.0% | 5.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | $43.2M |
8季度趋势，按日历期对齐
经营现金流CPIXSWKH
| Q4 25 | $3.0K | $27.3M | ||
| Q3 25 | $187.2K | $906.0K | ||
| Q2 25 | $843.8K | $7.8M | ||
| Q1 25 | $3.9M | $8.3M | ||
| Q4 24 | $1.9M | $23.0M | ||
| Q3 24 | $475.5K | $6.3M | ||
| Q2 24 | $-855.7K | $5.4M | ||
| Q1 24 | $-2.1M | $4.4M |
自由现金流CPIXSWKH
| Q4 25 | $3.0K | $26.8M | ||
| Q3 25 | $163.4K | $557.0K | ||
| Q2 25 | $817.3K | $7.7M | ||
| Q1 25 | $3.9M | $8.2M | ||
| Q4 24 | $1.9M | $22.9M | ||
| Q3 24 | $460.1K | $6.3M | ||
| Q2 24 | $-862.8K | $5.4M | ||
| Q1 24 | $-2.2M | — |
自由现金流率CPIXSWKH
| Q4 25 | 0.0% | 308.1% | ||
| Q3 25 | 2.0% | 5.1% | ||
| Q2 25 | 7.5% | 77.0% | ||
| Q1 25 | 32.9% | 69.1% | ||
| Q4 24 | 18.2% | 185.3% | ||
| Q3 24 | 5.1% | 60.4% | ||
| Q2 24 | -8.8% | 49.7% | ||
| Q1 24 | -25.6% | — |
资本支出强度CPIXSWKH
| Q4 25 | 0.0% | 5.9% | ||
| Q3 25 | 0.3% | 3.2% | ||
| Q2 25 | 0.2% | 0.6% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 0.0% | 1.1% | ||
| Q3 24 | 0.2% | 0.3% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.5% | 0.0% |
现金转化率CPIXSWKH
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | 3.10× | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPIX
暂无分部数据
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
